Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...nditions, and socio-demographic factors.
more
This document is intended to guide the care of COVID-19 patients as the response capacity of health systems is challenged; to ensure that COVID-19 patients can access life-saving treatment, without compromising public health objectives and safety of health workers.
It promotes two key messages:
...
1. Key public health interventions regardless of transmission scenario; and
2. Key action steps to be taken by transmission scenario to enable timely surge of clinical operations.
more
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st...rengthen the provision of services in an existing cancer centre. The publication provides the features of multidisciplinary cancer care and details the infrastructure, human resources and equipment for different services. This framework is expected to be used as a guide to implementation, taking into consideration the local context and resources.
more
Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to provide quality data which can be used for health research and patient treatment. As the use of laboratory... tests (often expensive) are increasingly becoming a part of medical diagnosis and research, generation of quality data would be a cost-effective and ethically sound strategy.
more
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other... information. In addition, the operational package can be used by international agencies and donors, by professional groups and nongovernmental organizations (NGOs).
more
The Lancet Global Health: DOI: http://dx.doi.org/10.1016/S2214-109X(16)30098-5
Open Access
Die Broschüre gibt Antworten auf wichtige Fragestellungen wie etwa zur Gleichberechtigung von Männern und Fraün, zur Meinungsfreiheit, zur Religions- und Glaubensfreiheit sowie zu Rechtsangelegenheiten vor einem staatlichen Gericht. Außerdem sind in der Broschüre Kontaktadressen zu staatlichen ...und nichtstaatlichen Beratungsangeboten gesammelt, an die Sie sich wenden können, wenn Sie z.B. bedroht werden oder Probleme in Ihrer Familie haben. In den Sprachen Deutsch, Englisch, Arabisch, Urdu, Paschtu und Dari
more
Soumis à l’Agence des États-Unis pour le développement international par le programme SIAPS (Systems for Improved Access to Pharmaceuticals and Services ou Programme des systèmes pour l’amélioration de l’accès aux produits et services pharmaceutiques). Arlington, VA : Management Sciences... for Health. Soumis à l’UNICEF par JSI, Arlington, VA : JSI Research & Training Institute, Inc.
Ce guide aidera les gestionnaires de programmes, les prestataires de service et les experts techniques lorsqu'ils réaliseront une quantification des besoins en intrants pour les 13 produits indispensables à la santé reproductive, maternelle, néonatale et infantile, dont la priorité a été établie par la Commission des Nations Unies pour les produits qui sauvent la vie des femmes et des enfants. Ce supplément à la quantification ne saurait être utilisé sans son guide principal – Quantification of Health Commodities: A Guide to Forecasting and Supply Planning for Procurement (Quantification des intrants de santé : un guide pour la prévision des achats et la planification des approvisionnements). * Ce supplément décrit les étapes à suivre pour la prévision de la consommation de ces intrants, en l’absence de données sur la consommation ou les services. Ensuite, afin de compléter la quantification, les utilisateurs doivent se référer au guide principal de quantification pour l’étape de planification de l’approvisionnement.
more
This report provides a synthesis of some of the most recent, high-quality literature on the security and political processes in Central African Republic produced up to the end of January 2016. It was prepared for the European Union’s Instrument Contributing to Stability and Peace, © European Unio...n 2016. The views expressed in this report are those of the author, and do not necessarily reflect the opinions of GSDRC, its partner agencies or the European Commission. This is the second review published by GSDRC on the situation in the Central African Republic. The first review of literature was published in June 2013 and provides a country analysis covering the period 2003-2013. It is available at: http://www.gsdrc.org/docs/open/car_gsdrc2013.pdf.
more
This Poster is available in English, French, Spanish, Russian, Chinese, Portuguese, Hausa and Arabic
The APCA Atlas provides the most up-to-date information of palliative care development in nearly all countries in Africa, using indicators derived, rated, and chosen by in-country African experts followed by a thorough Delphi consensus process with a panel of international experts on palliative care... indicators
more
3rd Edition – July 2017
www.msfaccess.org
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ...be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.
The guidance is based on the current knowledge of the 2019-nCoV and evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) and seasonal or pandemic influenza viruses.
more